{"subcategory":{"id":210,"name":"Solution for Inhalation","name_bn":null,"category_id":26,"subcat_slug":"solution-for-inhalation","subimg":null,"created_by":1,"updated_by":null,"created_at":"2025-04-27 11:34:35","updated_at":null},"products":[{"id":21591,"category_id":26,"subcategory_id":210,"subcategory_two_id":null,"subcategory_three_id":null,"brand_id":4,"brand":"ACME Laboratories Ltd.","country_id":1,"vendor_id":1,"name":"Rebreath 175 mcg\/3 ml Nebuliser Solution","name_bn":"Rebreath 175 mcg\/3 ml Nebuliser Solution","slug":"rebreath-175-mcg3-ml-nebuliser-solution","generic_name":null,"strength":"175 mcg","ppf":"SOLUTION","price":80,"user_id":1,"trade_price":68.6,"sku":"100713206200101","quantity":null,"discount_type":null,"discount":null,"short_desc":"Rebreath 175 mcg\/3 ml Nebuliser Solution","short_desc_bn":"Rebreath 175 mcg\/3 ml Nebuliser Solution","long_desc":"<p data-start=\"177\" data-end=\"383\" class=\"\"><strong data-start=\"177\" data-end=\"189\">Rebreath<\/strong> is a nebuliser solution containing <strong data-start=\"225\" data-end=\"252\">Revefenacin INN 175 mcg<\/strong> per 3 ml ampoule. <span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">It is indicated for the maintenance treatment of patients with <strong data-start=\"63\" data-end=\"111\">Chronic Obstructive Pulmonary Disease (COPD)<\/strong>.<\/span> <span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Revefenacin is a long-acting muscarinic antagonist (LAMA) that works by inhibiting the M3 receptor at the smooth muscle in the airways, leading to bronchodilation and improved airflow.<\/span><strong data-start=\"385\" data-end=\"413\" style=\"font-size: 1rem;\">:<\/strong><\/p><ul data-start=\"414\" data-end=\"698\">\r\n<li data-start=\"414\" data-end=\"453\" class=\"\">\r\n<p data-start=\"416\" data-end=\"453\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"21\" data-is-only-node=\"\">Recommended Dose:<\/strong> One ampoule (175 mcg) inhaled once daily using a standard jet nebuliser with a mouthpiece.<\/span><\/p>\r\n<\/li>\r\n<li data-start=\"454\" data-end=\"495\" class=\"\">\r\n<p data-start=\"456\" data-end=\"495\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"10\" data-is-only-node=\"\">Route:<\/strong> Oral inhalation via nebuliser.<\/span><\/p>\r\n<\/li>\r\n<li data-start=\"496\" data-end=\"537\" class=\"\">\r\n<p data-start=\"498\" data-end=\"537\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"9\" data-is-only-node=\"\">Note:<\/strong> Do not swallow or inject the solution.<\/span><\/p>\r\n<\/li>\r\n<li data-start=\"538\" data-end=\"698\" class=\"\">\r\n<p data-start=\"540\" data-end=\"698\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"24\" data-is-only-node=\"\">Special Populations:<\/strong> Not recommended for use in children and adolescents under 18 years.<\/span> <span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">No dosage adjustment is required for patients with renal impairment.<\/span> <span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Safety has not been established in patients with hepatic impairment.<\/span><\/p>\r\n<\/li>\r\n<\/ul><p data-start=\"700\" data-end=\"716\" class=\"\"><strong data-start=\"700\" data-end=\"716\">Precautions:<\/strong><\/p><ul data-start=\"717\" data-end=\"881\">\r\n<li data-start=\"717\" data-end=\"758\" class=\"\">\r\n<p data-start=\"719\" data-end=\"758\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Do not initiate treatment during acutely deteriorating or life-threatening episodes of COPD.<\/span><\/p>\r\n<\/li>\r\n<li data-start=\"759\" data-end=\"800\" class=\"\">\r\n<p data-start=\"761\" data-end=\"800\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Use with caution in patients with narrow-angle glaucoma or urinary retention.<\/span><\/p>\r\n<\/li>\r\n<li data-start=\"801\" data-end=\"881\" class=\"\">\r\n<p data-start=\"803\" data-end=\"881\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Avoid coadministration with other anticholinergic-containing drugs.<\/span><\/p>\r\n<\/li>\r\n<\/ul><p data-start=\"883\" data-end=\"900\" class=\"\"><strong data-start=\"883\" data-end=\"900\">Side Effects:<\/strong><\/p><p>\r\n\r\n\r\n\r\n\r\n\r\n<\/p><ul data-start=\"901\" data-end=\"1023\">\r\n<li data-start=\"901\" data-end=\"942\" class=\"\">\r\n<p data-start=\"903\" data-end=\"942\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Common: Cough, runny nose, upper respiratory tract infection, headache.<\/span><\/p>\r\n<\/li>\r\n<li data-start=\"943\" data-end=\"1023\" class=\"\">\r\n<p data-start=\"945\" data-end=\"1023\" class=\"\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Serious: Glaucoma, eye pain, blurred vision, painful urination, rash, swelling of the face, mouth, and tongue.<\/span><\/p><\/li><\/ul>","image":"202505040836Rebreath 175 mcg ml Nebuliser Solution.jpg","hot_deals":null,"featured":null,"special_offer":null,"special_deals":null,"status":1,"typeof_medicine":null,"is_color":null,"meta_title":"Rebreath 175 mcg\/3 ml Nebuliser Solution","meta_description":"Rebreath is a nebuliser solution containing Revefenacin INN 175 mcg per 3 ml ampoule. It is indicated for the maintenance treatment of patients with Chronic Obstructive Pulmonary Disease (COPD). Revefenacin is a long-acting muscarinic antagonist (LAMA) that works by inhibiting the M3 receptor at the smooth muscle in the airways, leading to bronchodilation and improved airflow.:\r\n\r\nRecommended Dose: One ampoule (175 mcg) inhaled once daily using a standard jet nebuliser with a mouthpiece.\r\n\r\nRoute: Oral inhalation via nebuliser.\r\n\r\nNote: Do not swallow or inject the solution.\r\n\r\nSpecial Populations: Not recommended for use in children and adolescents under 18 years. No dosage adjustment is required for patients with renal impairment. Safety has not been established in patients with hepatic impairment.\r\n\r\nPrecautions:\r\n\r\nDo not initiate treatment during acutely deteriorating or life-threatening episodes of COPD.\r\n\r\nUse with caution in patients with narrow-angle glaucoma or urinary retention.\r\n\r\nAvoid coadministration with other anticholinergic-containing drugs.\r\n\r\nSide Effects:\r\n\r\n\r\nCommon: Cough, runny nose, upper respiratory tract infection, headache.\r\n\r\nSerious: Glaucoma, eye pain, blurred vision, painful urination, rash, swelling of the face, mouth, and tongue.","created_at":"2025-04-27T11:05:05.000000Z","updated_at":"2025-05-04T08:36:27.000000Z"}]}